BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15981100)

  • 21. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
    Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
    Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
    J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
    Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
    Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.
    Judkins AR; Burger PC; Hamilton RL; Kleinschmidt-DeMasters B; Perry A; Pomeroy SL; Rosenblum MK; Yachnis AT; Zhou H; Rorke LB; Biegel JA
    J Neuropathol Exp Neurol; 2005 May; 64(5):391-7. PubMed ID: 15892296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
    Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas.
    Zakrzewska M; Wojcik I; Zakrzewski K; Polis L; Grajkowska W; Roszkowski M; Augelli BJ; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2005 Jan; 156(2):179-82. PubMed ID: 15642401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors.
    Alarcon-Vargas D; Zhang Z; Agarwal B; Challagulla K; Mani S; Kalpana GV
    Oncogene; 2006 Feb; 25(5):722-34. PubMed ID: 16302003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma.
    Mueller W; Eum JH; Lass U; Paulus W; Sarkar C; Bruck W; von Deimling A
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):304-7. PubMed ID: 15175083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
    Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
    Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA
    Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
    Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
    Donner LR; Wainwright LM; Zhang F; Biegel JA
    Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical teratoid/rhabdoid tumors may show morphological and immunohistochemical features seen in choroid plexus tumors.
    Schittenhelm J; Nagel C; Meyermann R; Beschorner R
    Neuropathology; 2011 Oct; 31(5):461-7. PubMed ID: 21276081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors.
    Chakravadhanula M; Ozols VV; Hampton CN; Zhou L; Catchpoole D; Bhardwaj RD
    Cancer Genet; 2014 Sep; 207(9):425-8. PubMed ID: 25085602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
    Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
    Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
    Packer RJ; Biegel JA; Blaney S; Finlay J; Geyer JR; Heideman R; Hilden J; Janss AJ; Kun L; Vezina G; Rorke LB; Smith M
    J Pediatr Hematol Oncol; 2002; 24(5):337-42. PubMed ID: 12142780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.